Metral
Markets

Codex Labs to Present Pediatric Eczema Study Showing 95% SCORAD Reduction Without Steroids at SPD 2026 Annual Meeting

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="left">SAN JOSE, California, July 02, 2026 (GLOBE NEWSWIRE) -- Codex Labs Corporation, a Silicon Valley biotech skincare company specializing in plant-based solutions for inflammatory skin conditions, today announced its participation in...

Published July 2, 2026 · Category: Markets

Overview

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="left">SAN JOSE, California, July 02, 2026 (GLOBE NEWSWIRE) -- Codex Labs Corporation, a Silicon Valley biotech skincare company specializing in plant-based solutions for inflammatory skin conditions, today announced its participation in...

Source

Originally published at markets.businessinsider.com.

Related Articles

CD
Metral Newsroom

Metral covers global markets, stocks, crypto and the economy — desk research and data-driven analysis. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.